Article

Fresh-frozen osteochondral allograft reconstruction of a giant cell tumor of the talus.

Department of Orthopaedic Surgery, Akron General Medical Center, 224 West Exchange St, Akron, OH 44302, USA.
The Journal of Foot and Ankle Surgery (Impact Factor: 0.86). 05/2007; 46(3):144-8. DOI: 10.1053/j.jfas.2006.10.004
Source: PubMed

ABSTRACT The use of fresh-frozen osteochondral allografts has been reported for the treatment of talar fractures, osteochondral lesions, and tumors of the calcaneus. Currently, we are unaware of any reports in the literature addressing the use of fresh-frozen osteochondral allograft for the treatment of giant cell tumors in the talus. We report our attempt to eradicate an aggressive giant cell tumor of the talus while minimizing morbidity and loss of function via reconstruction with a fresh-frozen osteochondral allograft. This is the first report in the literature to propose such a treatment option for giant cell tumors in the talus. The patient was informed that a report of this case would be submitted for publication.

0 Bookmarks
 · 
67 Views
  • [Show abstract] [Hide abstract]
    ABSTRACT: Osteochondromas are commonly encountered benign tumours and they are characterized by cartilage capped bony growths that project from the surface of the affected bone. Osteochondromas tend to grow eccentrically rather than centrifugally. We are reporting a case of an 18-year-old male, who had presentation of a large, hard, irregular swelling over anterolateral aspect of his right leg. There was no neurovascular deficit in the extremity. Computed tomography showed that the origin of the tumour was probably proximal fibula. En-block excision of mass was done. A histopathological examination confirmed the diagnosis of a benign osteochondroma. Patient had uneventful recovery without any evidence of recurrence.
    Journal of clinical and diagnostic research : JCDR. 04/2014; 8(4):LD01-3.
  • [Show abstract] [Hide abstract]
    ABSTRACT: Giant cell tumor in small bones is a rare condition characterized by extensive bony destruction and a high recurrence rate. Intralesional excision with curettage and autologous bone grafting has been used as a standard treatment method for giant cell tumor of the bones. We report the case of a 30-year-old female with giant cell tumor of the talar body. She was followed up for 19 years after intralesional curettage and autologous bone grafting treatment.
    The Journal of foot and ankle surgery: official publication of the American College of Foot and Ankle Surgeons 05/2014;
  • [Show abstract] [Hide abstract]
    ABSTRACT: Giant cell tumour (GCT) is a primary benign neoplasm of bone. It is classically described as a locally invasive tumour that occurs close to the joint of a mature bone. It accounts for 5% of all skeletal tumours. It usually originates from long bones. Giant Cell Tumour of the small bones of the hand and foot are relatively uncommon. Giant Cell Tumour of talus is a rare occurrence. We report a rare presentation of giant cell tumour of the talus in a 62-year-old farmer treated by talectomy and tibiocalcaneal fusion, who later presented with features suggestive of recurrence and secondaries in chest within six months following surgical resection of the primary. Below knee amputation was performed to manage the recurrence. At two years follow-up the patient showed no further progression of pulmonary metastasis or local recurrence.
    Journal of clinical and diagnostic research : JCDR. 07/2014; 8(7):LD01-3.